process (Example: a contrast dye used during an x-ray)
What three incentives does it offer to drug companies to develop orphan drugs?
(2) the patient can easily diagnose and monitor his or her own condition when using the OTC drug,
(3) the OTC drug has a low rate of side effects/toxicity and a low potential for abuse, and (4) use of the OTC drug does
not require the patient to have any special monitoring or ongoing tests
*People taking statin drugs are tested periodically for liver function abnormalities.